Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 FLEXPEN

0

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+FLEXPEN
Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+FLEXPEN

Novolog Mix 70/30 Flexpen is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.

This drug has seventy patent family members in twenty-two countries.

The generic ingredient in NOVOLOG MIX 70/30 FLEXPEN is insulin aspart protamine recombinant; insulin aspart recombinant. Two suppliers are listed for this compound. Additional details are available on the insulin aspart protamine recombinant; insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!